reviewThe LancetFeb 13, 2014GREEN OA

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

PCPatricia CortazarLZLijun ZhangMUMichael UntchKMKeyur MehtaJPJoseph P. Costantino

United States Food and Drug Administration · Helios Hospital Berlin-Buch · +23 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

4,674
total citations
FWCI
87.38
Percentile
100%
References
31
Citations per year

Authors

37

Topics & keywords

Topics
Keywords
  • Pathological
  • Breast cancer
  • Medicine
  • Clinical trial
  • Clinical endpoint
  • Oncology
  • Internal medicine
  • Surrogate endpoint
No related works found for this paper.

Funding